### 57624 Federal Register / Vol. 78, No. 182 / Thursday, September 19, 2013 / Notices

drugs have been limited to those drugs for which the beneficiary has a prescription for a drug in the same class and for which a clinically effective OTC drug is also available. The current demonstration is scheduled to end in November 2014. In the National Defense Authorization Act for Fiscal Year 2013, Congress authorized the Department to provide Over the Counter (OTC) drugs to beneficiaries under regulations prescribed by the Secretary. Although the Department could now cease the demonstration and implement this new Congressional authority, it is now considering the viability of adding some drugs, such as the Plan B One-Step (levonorgestrel) which is an OTC product for all women of child-bearing potential that does not require a prescription. It was decided that the most efficient method of testing this new criteria was by modification to the current demonstration.

**DATES :**  This demonstration project will continue through until November 30, 2016 in order to provide adequate time to implement and evaluate the substantive changes allowing the DoD toprovide drugs, such as the Plan B OneStep, that are in the class of drugs normally requiring a prescription but which the FDA has granted an exception to the prescription requirement.

**FOR FURTHER INFORMATION CONTACT :**  Captain Nita Sood, TRICARE Management Activity, Pharmaceutical Operations Directorate, telephone (703)

681–2890.

**SUPPLEMENTARY INFORMATION :**  Background

Section 705 of the John Warner National Defense Authorization Act for 2007 directed the Secretary to conduct a demonstration project under 10 United States Code (U.S.C.) 1092 to allow certain over-the-counter (OTC) medications to be included on the uniform formulary under 10 U.S.C. 1074g. On June 15, 2007, the Department of Defense published a notice in the Federal Register (FR) (72 FR 33208–33210) implementing the demonstration project until the implementation of the combined TRICARE mail and retail contract (TPharm) which was on November 4, 2009. In order to more thoroughly evaluate the clinical and cost effectiveness of OTC drugs as well as beneficiary satisfaction with the project, the Department published a notice in the FR (74 FR 66626–66627) on December 16, 2009 that extended the demonstration project through November 4, 2012. The Department determined that continuation of the demonstration project for an additional 2 years was necessary to provide the Secretary with sufficient information to fully evaluate the project. The demonstration project continues to be authorized by 10 U.S.C. 1092. Section 702 of the National Defense Authorization Act for Fiscal Year 2013 authorized the Department to provide OTC pharmaceuticals under terms prescribed by the Secretary. This authorization would allow the Department to implement its current demonstration under its current terms. These terms have been to authorize the provision of OTC drugs when the beneficiary had been receiving prescription drugs in the same class and a clinically effective OTC was available. These drugs were treated as generic prescription medications, except that the need for a prescription and/or a copay were waived. The OTC drugs must have been recommended by the DoD Pharmacy and Therapeutics Committee and approved by the Assistant Secretary of Defense, (Health Affairs) prior to inclusion on the formulary. On June 20, 2013, the Food and Drug Administration (FDA) announced the use of Plan B One-Step (levonorgestrel) emergency contraceptive as an over-the-counter product ‘‘for all women of child-bearing potential without age or point-of-sale restrictions.’’ Contraceptive drugs are a type of drug which normally would require a prescription prior to dispensing, however the FDA made an exception for this particular drug. The statute governing the Department’s pharmacy program, 10 U.S.C. 1074g, requires the Department to make available to its beneficiaries all prescription drugs approved by the FDA. The current issue for the Department regarding this drug, and any drugs for which the FDA might issue similar exceptions and mandates, is to determine how best to implement this requirement in our regulations. The modifications to the current demonstration are designed to help the Department determine whether these drugs can be treated in the same manner as the other OTC drugs which moved from prescription to non-prescription

status.

Modification of the Demonstration Project

(1) Inclusion of the Over-the-Counter Plan B One-Step Emergency Contraceptive (levonorgestrel).

(2) OTC availability of Plan B OneStep Emergency Contraceptive (levonorgestrel) through the demonstration project will be at retail dispensing venue. Eligibility includes all active duty service women and female beneficiaries of child-bearing potential, without age restrictions. All military treatment facility (MTF) pharmacies carry OTC Plan B One-Step, and provide it to all active duty service women and female beneficiaries of child-bearing potential, without age restrictions, at no cost. The OTC Plan B One-Step Emergency Contraceptive (levonorgestrel) will not be available through the demonstration project at the TRICARE mail order program because it would be clinically inappropriate to take OTC Plan B One-Step Emergency Contraceptive (levonorgestrel) after 72 hours (3 days).

(3) Eligible beneficiaries will not require a written prescription for Plan B One-Step Emergency Contraceptive (levonorgestrel). The beneficiary simply presents to the retail pharmacy and which will process the request identically to all other pharmacy claims.

(4) Cost sharing requirements. The cost sharing will be zero copay.

(5) Period of demonstration. The demonstration project will continue until November 30, 2016.

Dated: September 16, 2013. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense.

[FR Doc. 2013–22833 Filed 9–18–13; 8:45 am]

**BILLING CODE 5001–06–P**

**DEPARTMENT OF DEFENSE**

**Department of the Army; Corps of Engineers** 

**Availability of a Draft Integrated Feasibility Report (Feasibility Study/**  **Environmental Impact Statement/ Environmental Impact Report), Los**  **Angeles River Ecosystem Restoration Study, City of Los Angeles, Los**  **Angeles County, CA**

**AGENCY :**  Department of the Army, U.S. Army Corps of Engineers, DoD.

**ACTION :**  Notice of availability.

**SUMMARY :**  The U.S. Army Corps of Engineers (Corps) in conjunction with the City of Los Angeles (City) announces the availability of a Draft Integrated Feasibility Report (IFR), which includes a Draft Feasibility Study (FS) and Environmental Impact Statement/ Environmental Impact Report (EIS/EIR) for the Los Angeles River Ecosystem Restoration Study, Los Angeles County, CA, for review and comment. The study evaluates alternatives for the purpose of restoring 11 miles of the Los Angeles River from approximately Griffith Park


### 57625 Federal Register / Vol. 78, No. 182 / Thursday, September 19, 2013 / Notices

to downtown Los Angeles while maintaining existing levels of flood risk management. Restoration includes creation and reestablishment of historic riparian strand and freshwater marsh habitat to support increased populations of wildlife and enhance habitat connectivity within the study area, as well as to provide opportunities for connectivity to ecological zones such as the Santa Monica Mountains, Verdugo Hills, Elysian Hills, and San Gabriel Mountains. Restoration also includes the reintroduction of ecological and physical processes such as a more natural hydrologic and hydraulic regime that reconnects the river to historic floodplains and tributaries, reduced flow velocities, increased infiltration, improved natural sediment processes, and improved water quality. The study also evaluates opportunities for passive recreation that is compatible with the restored environment. A Notice of Intent for the EIS/EIR was published on November 28, 2008 (73 FR 72455).

**DATES :**  The Draft IFR is available for a 45-day review period from September 20, 2013 through November 5, 2013 pursuant to the National Environmental Policy Act (NEPA) and California Environmental Quality Act (CEQA). Written comments pursuant to the NEPA will be accepted until the close of public review at close of business on November 5, 2013.

**ADDRESSES :**  Questions or comments concerning the Draft IFR may be directed to: Josephine R. Axt, Ph.D.; Chief, Planning Division; U.S. Army Corps of Engineers; Los Angeles District; P.O. Box 532711; ATTN: Ms. Erin Jones, CESPL–PD–RN; Los Angeles, CA

90053–2325 or comments.lariverstudy@ usace.army.mil.

**FOR FURTHER INFORMATION CONTACT :**  Ms. Kathleen Bergmann, U.S. Army Corps of Engineers, Los Angeles District, Kathleen.M.Bergmann@usace.army.mil and Ms. Erin Jones, U.S. Army Corps of Engineers, Los Angeles District, Erin.L.Jones@usace.army.mil.

**SUPPLEMENTARY INFORMATION :**  As part of the public involvement process, notice is hereby given by the Corps Los Angeles District of a public meeting to be held at the Los Angeles River Center and Gardens (Atrium), 570 West Avenue 26, Los Angeles, CA 90065 from 5:30 p.m. to 7:30 p.m. on Thursday, October 17, 2013. The public meeting will allow participants the opportunity to comment on the IFR. Attendance at the public hearing is not necessary to provide comments. Written comments may also be given to the contacts listed under **ADDRESSES**

. The document is available for review

at:

(1) online at http://1.usa.gov/ 1ad0K9z.

(2) Arroyo Seco Regional Branch Library; 6145 N. Figueroa Street, Los Angeles, CA 90042; CD and Hard Copy.

(3) Los Angeles Central Library; 630 W 5th Street Los Angeles, CA 90071; CD and Hard Copy.

(4) Atwater Village Branch Library; 3379 Glendale Boulevard, Los Angeles, CA 90039; CD and Hard Copy.

(5) Cypress Park Branch Library; 1150 Cypress Avenue, Los Angeles CA 90065;
CD.

(6) Lincoln Heights Branch Library; 2530 Workman Street, Los Angeles, CA 90031; CD.

(7) Chinatown Branch Library; 639 N. Hill Street, Los Angeles, CA 90012; CD.

(8) Little Tokyo Branch Library; 203 S. Los Angeles Street, Los Angeles CA 90012; CD.

(9) Benjamin Franklin Branch Library; 2200 E. First Street, Los Angeles, CA 90033; CD.

Kimberly M. Colloton, Colonel, U.S. Army, Commander and District Engineer.

[FR Doc. 2013–22797 Filed 9–18–13; 8:45 am]

**BILLING CODE 3720–58–P**

**DEPARTMENT OF ENERGY**

**Federal Energy Regulatory Commission** 

**Combined Notice of Filings**

Take notice that the Commission has received the following Natural Gas Pipeline Rate and Refund Report filings:
Filings Instituting Proceedings

Docket Numbers: RP13–1323–000. Applicants: Questar Pipeline Company.

Description: QPC Statement of Rates to be effective 8/10/2013.

Filed Date: 9/11/13. Accession Number: 20130911–5097. Comments Due: 5 p.m. ET 9/23/13. Any person desiring to intervene or protest in any of the above proceedings must file in accordance with Rules 211 and 214 of the Commission’s Regulations (18 CFR 385.211 and 385.214) on or before 5:00 p.m. Eastern time on the specified comment date. Protests may be considered, but intervention is necessary to become a party to the proceeding.
Filings in Existing Proceedings

Docket Numbers: RP13–1223–002. Applicants: National Fuel Gas Supply Corporation. Description: Errata—ACA 2013— RP13–1223 to be effective 10/1/2013.

Filed Date: 9/11/13. Accession Number: 20130911–5049. Comments Due: 5 p.m. ET 9/18/13. Any person desiring to protest in any of the above proceedings must file in accordance with Rule 211 of the Commission’s Regulations (18 CFR 385.211) on or before 5:00 p.m. Eastern time on the specified comment date.

The filings are accessible in the Commission’s eLibrary system by clicking on the links or querying the docket number.

eFiling is encouraged. More detailed information relating to filing requirements, interventions, protests, service, and qualifying facilities filings can be found at: http://www.ferc.gov/ docs-filing/efiling/filing-req.pdf . For other information, call (866) 208–3676 (toll free). For TTY, call (202) 502–8659.

Dated: September 12, 2013. Nathaniel J. Davis, Sr., Deputy Secretary.

[FR Doc. 2013–22747 Filed 9–18–13; 8:45 am]

**BILLING CODE 6717–01–P**

**DEPARTMENT OF ENERGY**

**Federal Energy Regulatory Commission** 

**[Docket No. CP13–83–000]**

**Arlington Storage Company, LLC; Notice of Availability of the**  **Environmental Assessment for the Proposed Gallery 2 Expansion Project** 

The staff of the Federal Energy Regulatory Commission (FERC or Commission) has prepared an environmental assessment (EA) for the Gallery 2 Expansion Project, proposed by Arlington Storage Company, LLC (Arlington) in the above-referenced docket. Arlington requests authorization to convert two existing salt caverns, known as Gallery 2, to natural gas storage at its Seneca Lake Storage facility in Schuyler County, New York. The conversion of the Gallery 2 caverns to natural gas storage would add 0.55 billion cubic feet (Bcf) of working gas capacity, and 0.20 Bcf of base gas capacity to the Seneca Lake Storage facility, increasing the total working gas capacity from 1.45 Bcf to 2.0 Bcf.

The EA assesses the potential environmental effects of the construction and operation of the Gallery 2 Expansion Project in accordance with the requirements of the National Environmental Policy Act (NEPA) of 1969. The FERC staff concludes that approval of the proposed